All Categories
EN

Thús>Products>Finished farmaseutyske produkten>Antibiotika en antimykrobiaal

0.5g, 1.0g Ceftriaxone Natrium foar ynjeksje


Berteplak:Sina
Merknamme:FEIYUE
Minimaler bestellingsgrutte:100000pcs
Packaging Details:10ml tubular flesje mei filp-off, 1's / doaze, 10's / doaze, 50's / doaze
Levertiid:30days
Betellingsbetingsten:TT, L / C
Oanwizing

Ceftriaxone is used to treat the following serious infections when they are caused by susceptible organisms (see Action for a full list):
– lower respiratory tract infection
– skin and skin structure infections
– urinary tract infections, uncomplicated and complicated
– uncomplicated gonorrhoea
– bacterial blood infection (sepsis)
– bone infections
– joint infections
– meningitis
Ceftriaxone can also be used in the prevention of infection during surgery such a vaginal or abdominal hysterectomy, gall bladder removal, contaminated surgical procedures (eg: bowel surgery) and coronary artery bypass graft surgery.
As with the treatment of all infections, culture and sensitivity studies should be undertaken before institution of treatment if possible.


Spesifikaasjes

0.5g10ml tubular flesje mei filp-off, 1's / doaze, 10's / doaze, 50's / doaze
1.0g10ml tubular vial with   filp-off,1's/box, 10's/box, 50's/box


Aksje

Ceftriaxone is a broad spectrum antibiotic from the cephalosporin family. It is a known as a third generation cephalosporin, and is active against a number of bacteria not killed by first or second generation cephalosporins. Ceftriaxone kills bacteria by interfering with production of proteins important for their cell walls. It is active against a number of important and well-known organisms including:
– Staphylococcus aureus (but not MRSA)
– E. coli
– Neisseria meningitidis (meningococcus)
– N. gonorrhoeae (cause of gonorrhoea)
Ceftriaxone also kills some important causative organisms of respiratory tract infections, Haemophilus influenzae, Streptococcus pneumoniae and Klebsiella pneumoniae. Some strains of Pseudomonas aeruginosa, the bug that causes dangerous hospital infections, are also killed. A number of other bacteria responsible for a wide range of infections are also susceptible to Ceftriaxone.

Dose advice

Rocephin may be administered intravenously or intramuscularly.
folwoeksenen
– recommended daily dose is 1-2g once a day or in equally divided doses twice a day
– dose is determined based on severity of infection
Uncomplicated gonorrhoea
– single IM dose of 250mg
Surgical prophylaxis
– single dose of 1g should be administered ¨ö to 2 hours before surgery
bern
– 50-75mg/kg/day as one dose or divided doses
– dose not to exceed 2g/day
– dose should be divided and given every 12 hours in meningitis
Duration fan terapy
– in general, therapy should be continued for at least two days after the symptoms of the infection have disappeared
– usual duration is 4-14 days
– treatment may be much longer for certain infections, eg: bone infection
– prolonged therapy increases risk of adverse effects
– infections caused by Streptococcus pyogenes should be treated for no less than 10 days
Renale beheining
– plasma levels should be monitored in patients with impaired renal and hepatic function, and patients with severe renal impairment
– serum levels should not exceed 280mcg/ml
Bestjoer
– all prepared solutions should be used as soon as possible and retain their efficacy for six hours at room temperature
Intramuskulêre ynjeksje
– dissolve 250mg or 500mg in 2ml, or 1g in 3.5ml, of lignocaine 1% solution
– administer by deep intragluteal injection
– no more than 1g should be injected on each side
– injection without lignocaine is painful
– lignocaine solution should never be injected intravenously
Yntraveneuze ynjeksje
– dissolve 250mg or 500mg in 5ml, or 1g in 10ml, of water for injections
– administer by direct intravenous injection over 2-4 minutes
Intravenous infusion
– dissolve 2g in 400ml of any IV fluid NOT containing calcium
– administer by infusion over at least 30 minutes

Skema

S4

Gemeentlike side-effekten

Ceftriaxone is generally well tolerated. The following effects are experienced relatively commonly:
– diarrhoea
– nausea
– rash
– electrolyte disturbances
– pain and inflammation at injection site

Uncommon side-effekten

The following effects occur less often:
– vomiting
- hoofdpijn
- duizeligheid
– oral and vaginal thrush
– severe diarrhoea (pseudomembranous colitis)
Allergic reaction is uncommon but the symptoms are important to know and should be reported to your doctor:
– hives
– itching
- swelling
– trouble breathing
– wheezing
– widespread purple rash

Ifraach